<DOC>
	<DOCNO>NCT02892110</DOCNO>
	<brief_summary>Marijuana commonly use illicit drug . There high demand effective intervention cannabis use disorder , yet specific treatment develop . This study evaluate efficacy varenicline reduce marijuana use people use marijuana frequently .</brief_summary>
	<brief_title>Varenicline Treatment Cannabis Use Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>General Inclusion Criteria Must meet DSM5 criterion cannabis use disorder use cannabis least 3 day per week last 30 day . Must age 18 65 year . If female childbearing potential , must agree use acceptable method birth control duration trial . Must consent random assignment , willing commit medication ingestion . Must able read provide inform consent . Must body weight &gt; 110lbs ( 50kg ) BMI 18 32kg/m2 Must function intellectual level knowledge English language sufficiently allow accurate completion assessment . Additional Inclusion Criteria fMRI Eligibility Must righthanded . General Exclusion Criteria Women pregnant , nursing , plan become pregnant course study . Individuals severe renal impairment ( creatinine clearance le 30 mL per minute ) . Lifetime history DSM5 Bipolar I II Disorder , Schizophrenia psychotic disorder . Stably treat MDD , Dysthymia , GAD , Social Phobia , Specific Phobia diagnose acceptable ( i.e . dose medication prescribe least 2 month prior screen change current medication expect course trial ) . Suicidal ideation behavior within past 6 month . Subjects believe suicidal homicidal risk ( answer 'yes ' question 4 5 CSSRS ) refer assessment qualified mental health professional . Concomitant use psychotropic medication , exception stable dos ( defined dosing adjustment past two month ) nonMAOI antidepressant , nonbenzodiazepine anxiolytic , ADHD medication . Current use medication prescribe mania psychosis . Current use buproprion nortryptiline . Moderate severe noncannabis substance use disorder within past 60 day exception tobacco use disorder . Individuals take investigational agent within last 30 day baseline visit . Individuals clinically significant medical disorder lab abnormality . Any individual screening SGOT ( AST ) SGPT ( ALT ) great 3 time upper limit normal and/or total bilirubin great two time upper limit normal . Individuals clinically significant cardiovascular disease past 6 month ( e.g. , myocardial infarction , CABG , PTCA , severe unstable angina , serious arrhythmia , clinically significant ECG conduction abnormality . Individuals clinically significant cerebrovascular disease past 6 month TIA , CVA , stroke . Hypersensitivity varenicline . Individuals participate clinical trial investigative compound within last 60 day . Additional Exclusion Criteria fMRI Eligibility Any psychiatric medical issue , include claustrophobia , ferrous metal implant , pacemaker , electronic device would interfere ability participate successfully complete scanning procedure . Any person unable lie still within fMRI scanner required period time obtaine useful image ( use anxiolytic permit anxiety/claustrophobia related scanning procedure ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Marijuana use</keyword>
	<keyword>Varenicline/Chantix</keyword>
	<keyword>Motivational enhancement therapy</keyword>
</DOC>